Michelle M. Mezei

4.3k total citations
19 papers, 326 citations indexed

About

Michelle M. Mezei is a scholar working on Molecular Biology, Neurology and Clinical Biochemistry. According to data from OpenAlex, Michelle M. Mezei has authored 19 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Neurology and 5 papers in Clinical Biochemistry. Recurrent topics in Michelle M. Mezei's work include Mitochondrial Function and Pathology (9 papers), Metabolism and Genetic Disorders (5 papers) and Myasthenia Gravis and Thymoma (4 papers). Michelle M. Mezei is often cited by papers focused on Mitochondrial Function and Pathology (9 papers), Metabolism and Genetic Disorders (5 papers) and Myasthenia Gravis and Thymoma (4 papers). Michelle M. Mezei collaborates with scholars based in Canada, United States and Sweden. Michelle M. Mezei's co-authors include Andrew Eisen, Heather Stewart, Sandra Sirrs, Gerald Pfeffer, Peter M. Andersen, N. Kevin Wade, Ericka Simpson, Lee-Jun Wong, Suzanne Z. Powell and Nicola Brunetti‐Pierri and has published in prestigious journals such as Journal of the Neurological Sciences, Frontiers in Physiology and Muscle & Nerve.

In The Last Decade

Michelle M. Mezei

19 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michelle M. Mezei Canada 10 165 158 76 70 36 19 326
Michela Ranieri Italy 8 209 1.3× 151 1.0× 78 1.0× 74 1.1× 35 1.0× 8 350
Stephan Neudecker Germany 10 170 1.0× 106 0.7× 59 0.8× 31 0.4× 43 1.2× 14 333
Arianna Manini Italy 10 136 0.8× 110 0.7× 41 0.5× 18 0.3× 38 1.1× 24 299
Ryoko Koike Japan 13 161 1.0× 186 1.2× 34 0.4× 75 1.1× 62 1.7× 35 444
Christine Makowski Germany 10 229 1.4× 95 0.6× 31 0.4× 143 2.0× 62 1.7× 18 480
Laura Adobbati Italy 9 140 0.8× 70 0.4× 20 0.3× 81 1.2× 39 1.1× 13 253
A. Al‐Memar United Kingdom 9 138 0.8× 106 0.7× 20 0.3× 29 0.4× 125 3.5× 13 336
Akihiko Miyauchi Japan 11 189 1.1× 43 0.3× 20 0.3× 85 1.2× 45 1.3× 24 326
Osamu Yahara Japan 10 160 1.0× 132 0.8× 70 0.9× 9 0.1× 81 2.3× 24 354
Milena Janković Serbia 12 106 0.6× 152 1.0× 44 0.6× 17 0.2× 91 2.5× 37 337

Countries citing papers authored by Michelle M. Mezei

Since Specialization
Citations

This map shows the geographic impact of Michelle M. Mezei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle M. Mezei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle M. Mezei more than expected).

Fields of papers citing papers by Michelle M. Mezei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle M. Mezei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle M. Mezei. The network helps show where Michelle M. Mezei may publish in the future.

Co-authorship network of co-authors of Michelle M. Mezei

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle M. Mezei. A scholar is included among the top collaborators of Michelle M. Mezei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle M. Mezei. Michelle M. Mezei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Mezei, Michelle M., et al.. (2025). Loss-of-function mitochondrial DNA polymerase gamma variants cause vascular smooth muscle cells to secrete a diffusible mitogenic factor. Frontiers in Physiology. 15. 1488248–1488248. 1 indexed citations
2.
Vallance, Hilary, Michelle M. Mezei, Anna Lehman, et al.. (2023). Macrocytosis in Mitochondrial DNA Deletion Syndromes. Acta Haematologica. 146(3). 220–225. 2 indexed citations
3.
Alcántara, Mónica, Michelle M. Mezei, Steven K. Baker, et al.. (2021). Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy Management. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 49(1). 7–18. 13 indexed citations
4.
Yeung, Darwin F., Sandra Sirrs, Teresa S.M. Tsang, et al.. (2020). High rate of hypertension in patients with m.3243A>G MELAS mutations and POLG variants. Mitochondrion. 53. 194–202. 9 indexed citations
5.
Appendino, Juan Pablo, Steven K. Baker, Kristine Chapman, et al.. (2020). Practice Guidelines for Canadian Neurophysiology Laboratories During the COVID-19 Pandemic. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48(1). 25–30. 7 indexed citations
6.
7.
Huang, Kun, Kam Shojania, Kristine Chapman, et al.. (2018). Concurrent inflammatory myopathy and myasthenia gravis with or without thymic pathology: A case series and literature review. Seminars in Arthritis and Rheumatism. 48(4). 745–751. 24 indexed citations
8.
Flint, Julia, et al.. (2015). A Case of Good Syndrome Presumed Secondary to Metastatic Pancreatic Thymoma in a Patient Presenting With a Myasthenic Crisis Postthymectomy. Journal of Clinical Neuromuscular Disease. 16(3). 159–163. 5 indexed citations
9.
Arredondo, Juan, Sídney M. Gospe, Claudio Mazia, et al.. (2015). Choline Acetyltransferase Mutations Causing Congenital Myasthenic Syndrome: Molecular Findings and Genotype-Phenotype Correlations. Human Mutation. 36(9). 881–893. 20 indexed citations
10.
Hannah‐Shmouni, Fady, Sandra Sirrs, Michelle M. Mezei, Paula J. Waters, & André Mattman. (2013). Increased Prevalence of Hypertension in Young Adults with High Heteroplasmy Levels of the MELAS m.3243A>G Mutation. JIMD Reports. 12. 17–23. 15 indexed citations
11.
Al‐Thihli, Khalid, et al.. (2013). Performance of serum and dried blood spot acylcarnitine profiles for detection of fatty acid β‐oxidation disorders in adult patients with rhabdomyolysis. Journal of Inherited Metabolic Disease. 37(2). 207–213. 12 indexed citations
12.
Pfeffer, Gerald, et al.. (2012). Levator Palpebrae Biopsy and Diagnosis of Progressive External Ophthalmoplegia. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 39(4). 520–524. 1 indexed citations
13.
Pfeffer, Gerald & Michelle M. Mezei. (2012). Cardiac screening investigations in adult‐onset progressive external ophthalmoplegia patients. Muscle & Nerve. 46(4). 593–596. 8 indexed citations
14.
Pfeffer, Gerald, Sandra Sirrs, N. Kevin Wade, & Michelle M. Mezei. (2011). Multisystem Disorder in Late-Onset Chronic Progressive External Ophthalmoplegia. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 38(1). 119–123. 49 indexed citations
15.
Barton, Jason J.S., John A. Maguire, Michelle M. Mezei, Trevor A. Hurwitz, & Hannah Briemberg. (2010). Mitochondrial Pseudomyasthenia. Journal of Neuro-Ophthalmology. 30(3). 248–251. 2 indexed citations
16.
Eisen, Andrew, et al.. (2008). SOD1 gene mutations in ALS patients from British Columbia, Canada: Clinical features, neurophysiology and ethical issues in management. Amyotrophic Lateral Sclerosis. 9(2). 108–119. 66 indexed citations
17.
Milone, Margherita, Nicola Brunetti‐Pierri, Neeraj Kumar, et al.. (2008). Sensory ataxic neuropathy with ophthalmoparesis caused by POLG mutations. Neuromuscular Disorders. 18(8). 626–632. 52 indexed citations
18.
Stewart, Heather, Andrew Eisen, Jeremy Road, Michelle M. Mezei, & Markus Weber. (2001). Electromyography of respiratory muscles in amyotrophic lateral sclerosis. Journal of the Neurological Sciences. 191(1-2). 67–73. 27 indexed citations
19.
Mezei, Michelle M., Peter M. Andersen, Heather Stewart, Markus Weber, & Andrew Eisen. (1999). Motor system abnormalities in heterozygous relatives of a D90A homozygous CuZn-SOD ALS patient of Finnish extraction. Journal of the Neurological Sciences. 169(1-2). 49–55. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michela Ranieri Breakdown of academic impact, for papers by Stephan Neudecker Breakdown of academic impact, for papers by Arianna Manini Breakdown of academic impact, for papers by Ryoko Koike Breakdown of academic impact, for papers by Christine Makowski Breakdown of academic impact, for papers by Laura Adobbati Breakdown of academic impact, for papers by A. Al‐Memar Breakdown of academic impact, for papers by Akihiko Miyauchi Breakdown of academic impact, for papers by Osamu Yahara Breakdown of academic impact, for papers by Milena Janković
Rankless by CCL
2026